COMPOSITIONS BACTERIENNES ET CELLULAIRES POUR LE TRAITEMENT DU CANCER COLORECTAL ET METHODES D'EVALUATION D'UN PRONOSTIC POUR LES PATIENTS ATTEINTS DE CANCER COLORECTAL
The invention relates to the prognosis and treatment of colon cancer. Inparticular, the present invention concerns therole of intestinal microbiota in the anticancer immune response elicited byileal enterocytes succumbing to apoptosis, and providesimmunogenic compositions for treating colorectal cancer (CRC), as well assignatures for prognosing CRC evolution.